Background-We have previously reported that fosB mRNA is induced by hy
pertrophic stimuli (thrombin, angiotensin LI) but not proliferative st
imuli (platelet-derived growth factor, basic fibroblast growth factor)
in pulmonary arterial smooth muscle cells (PASMCs) (J Biol Chem. 1994
;9:6399-6404). Our aim in the present study was to investigate the pot
ential role of FosB in PASMC hypertrophy. Methods and Results-Adenovir
uses carrying sense or antisense fosB RNA expression cassettes were us
ed to infect cultured PASMCs with the aim of increasing or inhibiting
fosB expression, respectively. We examined whether fosB expression mod
ification affected the growth of quiescent PASMCs, thrombin-induced hy
pertrophy, or platelet-derived growth factor-induced proliferation. PA
SMC growth was assessed by daily cell number count, determination of [
H-3]leucine incorporation, and quantification of total cellular protei
n. Neither an increase nor a decrease in FosB protein expression cause
d a significant change in the growth of quiescent PASMCs over a period
of 96 hours, indicating that FosB alone is not sufficient to induce h
ypertrophy. Modification of FosB levels did not affect platelet-derive
d growth factor-induced PASMC proliferation. An increase in FosB expre
ssion did not augment thrombin-induced hypertrophy; however, inhibitio
n of FosB expression resulted in a diminution of thrombin-induced hype
rtrophy by 58 +/- 6% (P < 0.005). Conclusions-These results suggest th
at FosB is necessary but not sufficient fur thrombin-induced hypertrop
hy in cultured PASMCs.